We first recommended this incredible biotech stock in 2013. It's since realized a growth of 342%.
And better yet: it's expected to continue growing at an exponential rate.
By Michael A. Robinson, Defense + Tech Specialist, Money Morning • @Robinson_STI -
We first recommended this incredible biotech stock in 2013. It's since realized a growth of 342%.
And better yet: it's expected to continue growing at an exponential rate.
Here's why you should add stellar security to your portfolio...
By Michael A. Robinson, Defense + Tech Specialist, Money Morning • @Robinson_STI -
We first recommended this incredible biotech stock in 2013. It's since realized a growth of 342%.
And better yet: it's expected to continue growing at an exponential rate.
Here's why you should add stellar security to your portfolio...